Skip to main content
Signal8

Full Access with Signal8 Pro, $49/mo billed annually.

Hims & Hers Health, Inc. (HIMS) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit

$HIMSPress releaseSep 21, 2026, 1:00 PM ETRead the release

Law Offices of Howard G. Smith announced that investors with substantial losses in Hims & Hers Health can seek lead plaintiff status in a securities fraud class action before the November 2, 2026 deadline. The complaint alleges that between August 4, 2025 and July 29, 2026, defendants made misleading statements and failed to disclose that the company shared consumer health information with third-party advertising platforms and charged consumers for prescriptions before any medical consultation, conduct alleged to invite regulatory scrutiny and penalties.

Key figures

Class period end
2026-07-29
Class period start
2025-08-04
Lead plaintiff deadline
2026-11-02

AI analysis

Red flags2 · Pro

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.